Nasal defenses
Leyden Labs Secures $70 Million Funding to Develop Broad Protection Against Respiratory Viruses
Leyden Labs, Respiratory viruses, Influenza, Nasal defenses, Broad protection, PanFlu, Mucosal Protection Platform, Biotech funding
Actionable Insights Powered by AI
Leyden Labs, Respiratory viruses, Influenza, Nasal defenses, Broad protection, PanFlu, Mucosal Protection Platform, Biotech funding